Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study

Diabetes, Obesity and Metabolism

Volumn 11, Issue 1, 2009, Pages 33-40

  Gao, Yan ^a   Guo, X H ^a   Vaz, J A ^b  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b Clinical Development Centre   (China)

Author keywords

Biphasic insulin aspart 30; Clinical practice; Insulin analogue; Observational study; PRESENT study, type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; INSULIN ASPART; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; CHINESE; CLINICAL PRACTICE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIABETES CONTROL; DIET RESTRICTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 58149178751     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2008.00904.x     Document Type: Article

References (30)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431.
2. International Diabetes Federation. The Diabetes Atlas, 3rd edn. 2006. Available from URL: http://www.eatlas.idf.org/media. (Accessed 28 April, 2008).
3. Wong KC, Wang Z. Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. Diabetes Res Clin Pract 2006; 73: 126-134.
4. Gu D, Reynolds K, Duan X et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 2003; 46: 1190-1198.
5. Du S, Lu B, Zhai F, Popkin BM. A new stage of the nutrition transition in China. Public Health Nutr 2002; 5: 169-174.
6. Muntner P, Gu D, Wildman RP et al. Prevalence of physical activity among Chinese adults: Results from the International Collaborative Study of Cardiovascular Disease in Asia. Am J Public Health 2005; 95: 1631-1636.
7. Chan JC, Ng MC, Critchley JA, Lee SC, Cockram CS. Diabetes mellitus - a special medical challenge from a Chinese perspective. Diabetes Res Clin Pract 2001; 54 (Suppl. 1): S19-S27.
8. Songer TJ. The economic costs of NIDDM. Diabetes Metab Rev 1992; 8: 389-404.
9. Pan CY, Tian H, Liu GL, Li XJ, Fu ZZ, Chen JW. A survey of diabetes management in Chinese primary healthcare centers. Chin J Endocrinol Metab 2004; 20: 420-424.
10. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
11. Nathan DM, Buse JB, Davidson MB et al. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006; 29: 1963-1972.
12. Davidson J, Vexiau P, Cucinotta D, Vaz J, Kawamori R. Biphasic insulin aspart 30: Literature review of adverse events associated with treatment. Clin Ther 2005; 27 (Suppl. 2): S75-S88.
13. Kilo C, Mezitis N, Jain R, Mersey J, McGill J, Raskin P. Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/ 30, or NPH insulin in combination with metformin. J Diabetes Complications 2003; 17: 307-313.
14. Leiter LA, Ceriello A, Davidson JA et al. Postprandial glucose regulation: New data and new implications. Clin Ther 2005; 27 (Suppl. 2): S42-S56.
15. Christiansen JS, Vaz JA, Metelko Z, Bogoev M, Dedov I. Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes. Diabetes Obes Metab 2003; 5: 446-454.
16. Raskin P, Allen E, Hollander P et al. Initiating insulin therapy in type 2 diabetes: A comparison of biphasic and basal insulin analogs. Diabetes Care 2005; 28: 260-265.
17. Jacobsen LV, Sogaard B, Riis A. Pharmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine-retarded insulin aspart. Eur J Clin Pharmacol 2000; 56: 399-403.
18. Garber AJ. Premixed insulin analogues for the treatment of diabetes mellitus. Drugs 2006; 66: 31-49.
19. Garber AJ, Ligthelm R, Christiansen JS, Liebl A. Premixed insulin treatment for type 2 diabetes: Analogue or human? Diabetes Obes Metab 2007; 9: 630-639.
20. Boehm BO, Home PD, Behrend C, Kamp NM, Lindholm A. Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: A randomized trial in Type 1 and Type 2 diabetic patients. Diabet Med 2002; 19: 393-399.
21. Boehm BO, Vaz JA, Brondsted L, Home PD. Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes. Eur J Intern Med 2004; 15: 496-502.
22. Yang WY, Kawamori R, Valensi P, Gylvin T, Ligthelm R. Clinical profile of patients considered for BIAsp 30: Baseline characteristics from China, Japan and Poland from the IMPROVE TM study. Diabetes 2007; 56 (Suppl. 1): A627.
23. Yang W, Ji Q, Zhu D et al. Efficacy and safety of twice daily vs. thrice daily injections of biphasic insulin aspart 30 in insulin naïve patients with type 2 diabetes inadequately controlled with OADs. Diabetes 2007; 56 (Suppl. 1): A546.
24. Gumprecht J, Yang WY, Valensi P, Christensen T, Borzi V. Patient treatment satisfaction before starting biphasic insulin aspart 30 (BIAsp 30): IMPROVE™ study data from China, Japan and Poland. Diabetes 2007; 56 (Suppl. 1): A506.
25. Kawamori R, Gumprecht J, Hansen JB, Valensi P. Use of HbA1c in clinical practice: Baseline data from China, Japan and Poland from the IMPROVE™ study. Diabetes 2007; 56 (Suppl. 1): A530.
26. Sridhar GR. Two regimens of twice-daily premix insulin analogue: An observational study. Diabetes Res Clin Pract 2006; 71: 105-107.
27. Kvapil M, Swatko A, Hilberg C, Shestakova M. Biphasic insulin aspart 30 plus metformin: An effective combination in type 2 diabetes. Diabetes Obes Metab 2006; 8: 39-48.
28. Estey AL, Tan MH, Mann K. Follow-up intervention: Its effect on compliance behaviour to a diabetes regimen. Diabetes Educ 1990; 16: 291-295.
29. Mendoza A, Young NK, Chernoff A. Hypoglycemia in hospitalized adult patients without diabetes. Endor Pract 2005; 11: 91-96.
30. Guven M, Bayram F, Guven K, Kelestimur F. Evaluation of patients admitted with hypoglycaemia to a teaching hospital in Central Anatolia. Postgrad Med J 2000; 76: 150-152.